Inflammatory biomarkers and cardiac injury in COVID-19 patients
IntroductionCardiac injury has received considerable attention due to the higher risk of morbidity and mortality associated with coronavirus disease. However, in a developing country, there is a scarcity of data on cardiac injury in COVID-19 patients related to inflammatory biomarkers.MethodsTherefo...
Main Authors: | Ayesha Mumtaz, Erum Rehman, Mohammad Anisur Rahaman, Shazia Rehman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.1024535/full |
Similar Items
-
Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury – A Narrative Review
by: Luo Y, et al.
Published: (2021-07-01) -
Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study
by: Yi Bo, et al.
Published: (2022-09-01) -
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
by: Zhengchuan Zhu, et al.
Published: (2021-12-01) -
Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19
by: Sanaz Rezaeian, et al.
Published: (2023-12-01) -
Correlation of rheumatoid and cardiac biomarkers with cardiac anatomy and function in rheumatoid arthritis patients without clinically overt cardiovascular diseases: A cross-sectional study
by: Duangkamol Aiewruengsurat, et al.
Published: (2023-02-01)